SecBot SecBot
DEFA14A ·Filed Apr 24, 2026

LYEL

Lyell Immunopharma, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001140361-26-016688
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine annual filing with no material developments. Monitor the company's next earnings report for any significant updates.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$22.62
T+0 close · Apr 24, 2026 · via day close
Latest settled
−43.24%
T+60 · $12.84
Vs SPY
−48.01%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 27 $22.62entry
  2. T+1 · 7mo ago −5.00%α −4.51% · $21.49
  3. T+5 · 7mo ago −8.40%α −8.80% · $20.72
  4. T+20 · 6mo ago −27.63%α −32.59% · $16.37
  5. T+60 · 4mo ago −43.24%α −48.01% · $12.84
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Lyell Immunopharma filed a definitive proxy statement for its 2026 annual meeting, which includes routine director elections and executive compensation matters. The filing is standard for public companies and does not contain any material financial or strategic developments.

Key Financial Metrics

Vote
director election
Meeting
2026-04-24

Key Facts

  • Filing is a standard DEFA14A proxy statement for the 2026 annual meeting
  • Covers routine matters including director elections and executive compensation
  • No material financial or strategic developments disclosed
  • Standard annual filing for public companies

Financial Impact

No material financial impact from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-016688
Document: 0001140361-26-016688-index-headers.html0001140361-26-016688
Document: 0001140361-26-016688-index.html0001140361-26-016688
Document: 0001140361-26-016688.txt0001140361-26-016688

Track record

21 reports on LYEL

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +17.99% at T+60 after the Jun 8, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 13, 20263d ago S-3 Neutral 3/10 Entry $14.30 Now $14.65 +2.45% settles Nov 17
  2. Nov 12, 20264d ago Insider Cluster Bullish 6/10 Entry $14.30 to $14.65 Now $14.65 +2.45% ▲ +2.45% +4.36% vs SPY
  3. Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $16.86 to $15.64 Now $14.65 −13.11% ▼ −7.24% −6.88% vs SPY
  4. Nov 5, 202611d ago Insider Cluster Bullish 7/10 Entry $14.86 to $15.42 Now $14.65 −1.41% ▲ +3.77% +1.40% vs SPY
  5. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  6. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.00 to $14.86 Now $14.65 −2.33% ▼ −0.93% −1.25% vs SPY
  7. Nov 4, 202612d ago 8-K Bearish 5/10 Entry $15.43 to $15.00 Now $14.65 +5.06% ▲ +2.79% −1.62% vs SPY
  8. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.43 to $15.00 Now $14.65 −5.06% ▼ −2.79% +1.62% vs SPY
  9. Aug 25, 202611w ago Insider Cluster Neutral 4/10 Entry $14.80 to $14.61 Now $14.65 −1.01% ▼ −1.28% −1.94% vs SPY
  10. Jul 22, 202616w ago EFFECT Neutral 4/10 Entry $12.84 to $12.78 Now $14.65 +14.10% ▼ −0.47% +0.77% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026